Development, Piloting and Evaluation of an Evidence-based Informed Consent Form for Total Knee Arthroplasty (EvAb-Pilot)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04669483|
Recruitment Status : Recruiting
First Posted : December 16, 2020
Last Update Posted : May 18, 2021
Every medical intervention requires informed consent. Informed consent may include comprehensible information about the necessity and kind of the intervention, material risks and consequences or alternative treatments. Practitioners frequently use consent forms to support the physician-patient conversation and to document informed consent. Studies show, that informed consent forms used in practice, are heterogeneous.
This study aims at investigating the effects of evidence-based informed consent forms for Total Knee Replacement and related anaesthesia procedures.
Evidence-based informed consent forms include best and latest evidence in lay language. It is hypothesized that evidence-based informed consent forms - compared to standard consent forms - improve patients' risk perception, reduce anxiety of complications and reduce the nocebo effect (unspecific negative effects caused by the way of communicating risks).
To compare evidence-based and standard informed consent forms, an Interrupted Time Series pilot study will be conducted. It is planned to include 220 patients, who are scheduled for elective total knee replacement surgery.
The accompanying qualitative analyses ensure that the (German) legal requirements for informed consent are met.
|Condition or disease||Intervention/treatment|
|Consent Forms Osteoarthritis, Knee Arthroplasty, Replacement, Knee||Other: evidence-based informed consent form|
|Study Type :||Observational|
|Estimated Enrollment :||220 participants|
|Official Title:||Development, Piloting and Evaluation of an Evidence-based Informed Consent Form for Total Knee Arthroplasty|
|Actual Study Start Date :||March 22, 2021|
|Estimated Primary Completion Date :||February 2023|
|Estimated Study Completion Date :||March 2023|
Intervention group (post-interruption)
Patients receive evidence-based informed consent forms for total knee arthroplasty and related anaesthesia procedures
Other: evidence-based informed consent form
Evidence-based informed consent forms for total knee arthroplasty and related anesthesia procedures will be developed. The design of the evidence-based informed consent forms will be guided by an existing guideline on how to present evidence-based health information (guideline evidence-based health information) and nocebo research. The information will be presented in plain language. Benefits and harms of the procedures will be presented in absolute risk formats and in comparison with other interventions or placebo. Verbal presentations of risks lead to overestimations of risks and therefore, will not be applied exclusively. Gain and loss framing will be combined. To visualize important aspects, pictograms will be used. Information on uncertainty, missing or low quality evidence will be provided.
Control group (pre-interruption)
Patients receive standard consent forms (of the study centre) for total knee arthroplasty and related anaesthesia procedures
- Anxiety: Change from baseline anxiety after the informed consent procedure assessed by the surgical fear questionnaire and a numeric rating scale (0-10) [ Time Frame: Anxiety will be measured at the day of consultation - approximately 4 weeks before surgery - (baseline) and one day before surgery ]The surgical fear questionnaire is a validated questionnaire for measuring patient reported fear of surgery. The questionnaire includes the following items: fear of operation, fear of anaesthesia, postoperative pain, side effects, health deterioration, failed operation, incomplete recovery, long duration of rehabilitation.
- Nocebo-Effect: Proportion of patients with patient reported adverse events/complications and cummulaive number of adverse events/complications assessed by closed and open questions [ Time Frame: approximately three days after hospital discharge ]The occurence of specific adverse events/complications (e.g. postoperative nausea and vomitting) will be queried. In addition it will be queried whether other adverse events/ complications not mentioned before have occurred.
- Knowledge/risk perception: Proportion of correctly answered questions assessed by knowledge questions about benefits and risks of undergoing surgery [ Time Frame: One day before surgery ]The objective knowledge questions (e.g. correct risk assessment) will be derived when developing the evidence-based informed consent forms. The development will be based on previous experiences with the measure of informed choice.
- Mean satisfaction with the physician-patient-communication and informed consent form assessed by a numeric rating scale (0-10) [ Time Frame: One day before surgery ]Patients will be queried about their overall satisfaction with the physician-patient-communication and with the informed consent form using a numeric rating scale (0-10)
- Mean Quality of life (QoL) assessed by a numeric rating scale (0-10) [ Time Frame: approximately one month after hospital discharge ]Patients will be queried about their current overall quality of life assessed by a numeric rating scale (0-10)
- Mean pain and function of the knee assessed by the Oxford Knee Score [ Time Frame: approximately one month after hospital discharge ]The Oxford Knee Score (OKS) is a validated patient reported outcome measure for patients undergoing total knee arthroplasty, that consists of 12 questions about the individual's activities of daily live and how they have been affected by pain over the preceding four weeks.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04669483
|Contact: Alina Weise, M. Sc.||+49 221/9895741||Alina.Weise@uni-wh.de|
|Cologne Merheim Medical Center||Recruiting|
|Cologne, NRW, Germany, 51109|
|Principal Investigator:||Tim Mathes, Dr.||Institute for Research in Operative Medicine (IFOM), Witten/Herdecke University|